SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-006092
Filing Date
2023-03-02
Accepted
2023-03-02 17:05:23
Documents
12
Period of Report
2023-03-02
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20230302.htm   iXBRL 8-K 41219
  Complete submission text file 0001628280-23-006092.txt   181621

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20230302.xsd EX-101.SCH 1941
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20230302_lab.xml EX-101.LAB 25133
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20230302_pre.xml EX-101.PRE 13080
6 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20230302_htm.xml XML 11309
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 23700154
SIC: 2836 Biological Products, (No Diagnostic Substances)